SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ANTIVIRALS INC. http://www.antivirals.com

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jr who wrote (150)4/13/1999 11:06:00 AM
From: jr   of 167
 
just pulled of yahoo board:

By the Begining of May, there will be a marketing agreement announced, more than likely with Smith Kline.

This will be for the Avacine, colo-rectal application, getting ready for phase III testing. The agreement will disclose that the partner will:
Supply $15 million dollars immediately, pay for the ENTIRE Phase III process, and fork over another $10 million upon completion. The product will be marketed with the AVI Bio name as well as Smith Kline (could be Merck).
This is just one application for the avacine, the others pending with the same types of agreements to come are for Pancreatic, Prostate and Breast Application. All four are about a billion dollar market each. The Avacine is a substitute for chemotherapy with NO side effects. THIS IS HUGE!
Also on the burner is the Antisense RESTIN NG with a 2-4 billion dollar market.
I'm telling you, it is coming quickly, once the agreement comes out, hold on to your hats.
Remember Supergen? You'll see... Mark My Words!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext